Guidelines for the use of acitretin in psoriasis;Acitretina: guía de uso en psoriasis

Actas Dermo-Sifiliograficas

Volumn 104, Issue 7, 2013, Pages 598-616

  Carretero, G ^a,b   Ribera, M ^a,c   Belinchon I ^a,d   Carrascosa, J M ^a,e   Puig, Ll ^a,f   Ferrandiz, C ^a,e   Dehesa, L ^a,g   Vidal, D ^a,h   Peral, F ^a,i   Jorquera, E ^a,j   Gonzalez Quesada, A ^a,b   Munoz C ^a,k   Notario, J ^a,l   Vanaclocha, F ^a,m   Moreno, J C ^a,n  

^a Grupo de Psoriasis de la Academia Española de Dermatología y Venereología   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c Servicio de Oncología Médica   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^f HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^g MOUNT SINAI MEDICAL CENTER   (United States)

^h Angiologia Cirurgia Vascular I Endovascular   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^j HOSPITAL JUAN RAMÓN JIMÉNEZ   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^m HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

ⁿ HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

more..

Author keywords

Acitretin; Antipsoriasis systemic treatment; Guidelines; Psoriasis; Treatment

Indexed keywords

ETRETIN;

ADVERSE OUTCOME; ARTICLE; CLINICAL PRACTICE; DRUG CONTRAINDICATION; DRUG USE; PRACTICE GUIDELINE; PSORIASIS; TREATMENT INDICATION;

ACITRETIN; ACITRETINA; ANTIPSORIASIS SYSTEMIC TREATMENT; GUIDELINES; GUÍA; PSORIASIS; TRATAMIENTO; TRATAMIENTO SISTÉMICO ANTIPSORIÁSICO; TREATMENT;

ABNORMALITIES, DRUG-INDUCED; ACITRETIN; BIOTRANSFORMATION; CARDIOVASCULAR DISEASES; COMORBIDITY; DRUG ADMINISTRATION SCHEDULE; DRUG INTERACTIONS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATINOCYTES; METABOLIC SYNDROME X; PREGNANCY; PREGNANCY COMPLICATIONS; PSORIASIS; RECEPTORS, RETINOIC ACID; RISK ASSESSMENT; TETRACYCLINES;

EID: 84883279210     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/j.ad.2013.01.003     Document Type: Short Survey

References (146)

1. L. Dubertret Acitretin Ann Dermatol Venereol 138 2011 829 832
2. L.K. Dunn, L.R. Gaar, B.A. Yentzer, J.L. O'Neill, and S.R. Feldman Acitretin in dermatology: A review J Drugs Dermatol 10 2011 772 782
3. C.W. Lynde, J.N. Kraft, and C.B. Lynde Acitretin revisited Skin Therapy Lett 16 2011 1 4
4. M.T. Booij, and P.C. van de Kerkhof Acitretin revisited in the era of biologics J Dermatolog Treat 22 2011 86 89
5. A.D. Ormerod, E. Campalani, M.J. Goodfield BAD Clinical Standards Unit British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology Br J Dermatol 162 2010 952 963
6. M.F. Boehm, R.A. Heyman, S. Patel, R.B. Stein, and S. Nagpal Retinoids: Biological function and use in the treatment of dermatological diseases. Expert opinion investigational Drugs 4 1995 593 612
7. A.V. Vieira, W.J. Schneider, and P.M. Vieira Retinoids: Transport, metabolism and mechanism of action J Endocrinol 146 1995 201 207
8. S. Nagpal, and R.A. Chandratina Recent developments in receptor-selective retinoids Curr Pharm Des 6 2000 919 931
9. P.C.M. Van de Kerkhof Update on retinoid therapy of psoriasis in: an update on the use of retinoids in dermatology Dermatol Ther 19 2006 252 263
10. P. Berbis Retinoids: Mechanisms of action Ann Dermatol Venereol 137 Suppl 3 2010 S97 S103
11. X. Soria, and M. Ribera Biología de los receptores de los retinoides Piel 20 2005 68 73
12. R.A.S. Chandraratna Rational design of receptor-selective retinoids J Am Acad Dermatol 39 1998 S124 S128
13. W. Bollag Therapeutic effects of an aromatic acid analog on chemically induced skin papilomas and carcinomas of mice Eur J Cancer 10 1974 731 737
14. W. Bollag Vitamin A and retinoids, from nutrition to pharmacotherapy in dermatology and oncology Lancet 1 1983 860 863
15. D. Asselineau, B.A. Bernard, C. Bailly, and M. Darmon Retinoic acid improves epidermal morphogenesis Dev Biol 133 1989 322 335
16. H.P. Gollnick, and U. Dummler Retinoids Clin Dermatol 15 1997 799 810
17. J. Koo, Q. Nguyen, and C. Gambla Advances in psoriasis therapy Adv Dermatol 12 1997 47 72
18. B. Werner, M. Bresch, F.M. Brenner, and H.C. Lima Comparative study of histopathological and immunohistochemical findings in skin biopsies from patients with psoriasis before and after treatment with acitretin J Cut Pathol 35 2008 302 310
19. S. Gottlieb, E. Hayes, P. Gilleaudeau, I. Cardinale, A.B. Gottlieb, and J.G. Krueger Cellular actions of etretinate in psoriasis: Enhanced epidermal differentiation and reduced cell-mediated inflammation are unexpected outcomes J Cutan Pathol 23 1996 404
20. X. Niu, W. Cao, H. Ma, J. Feng, X. Li, and X. Zhang Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris J Dermatol 39 2012 1 6
21. C.S. Lee, and J. Koo A review of acitretin, a systemic retinoid for the treatment of psoriasis Expert Opin Pharmacother 6 2005 1725 1734
22. P.S. Yamauchi, D. Rizk, and N.J. Lowe Retinoid therapy for psoriasis Dermatol Clin 22 2004 467 476
23. T. Fredriksson, and U. Pettersson Severe psoriasis-oral therapy with a new retinoid Dermatologica 157 1978 238 244
24. R.A. Harper Specificity in the synergism between retinoic acid and EFG on the growth of adult human skin fibroblasts Exp Cell Res 178 1988 254 263
25. P. Dupuy, M. Bagot, M. Heslan, and L. Dubertret Synthetic retinoids inhibit the antigen-presenting properties of epidermal cells in vivo J Invest Dermatol 93 1989 455 459
26. R. Bauer, and C.E. Orfanos Effects of synthetic retinoids on human peripheral blood lymphocytes and polimorphonuclears in vivo W.J. Cunliffe, Retinoid therapy: A review of clinical and laboratory research 1984 MTP Press Boston 101 118
27. P.K. LeMotte, S. Keidel, and C.M. Apfel Characterization of synthetic retinoids with selectivity for retinoic acid or retinoid X nuclear receptors Biochim Biophys Acta 1289 1996 298 304
28. P. Chambon The retinoid signaling pathway: Molecular and genetic analysis Semin Cell Biol 5 1994 115 125
29. M. Pfhal The molecular mechanism of retinoid action. Retinoids today and tomorrow Retinoid Dermatol 44 1996 2 6
30. B.V. Diaz, M.C. Lenoir, A. Ladoux, C. Frelin, M. Demarchez, and S. Michel Regulation of vascular endothelial growth factor expression in human keratinocytes by retinoids J Biol Chem 275 2000 642 650
31. J.H. Saurat Retinoids and psoriasis: Novel issues in retinoid pharmacology and implications for psoriasis treatment J Am Acad Dermatol 41 1999 52 56
32. J.T. Elder, A. Aström, U. Pettersson, A. Tavakkol, A. Krust, and P. Kastner Retinoic acid receptors and binding proteins in human skin J Invest Dermatol 98 Suppl 1992 36S
33. D. Mucida, Y. Park, G. Kim, O. Turoskaya, I. Scott, and M. Kronenberg Reciprocal TH17 and regulatory T-cell differentiation mediated by retinoic acid Science 317 2007 256 260
34. E.A. Olsen, W.W. Weed, C.J. Meyer, and L.M. Cobo A double-blind, placebo controlled trial of acitretin for the treatment of psoriasis J Am Acad Dermatol 21 1989 681 686
35. L. Torok, L. Kadar, and J.M. Geiger Acitretin treatment of severe psoriasis Acta Dermatol Venereol Suppl (Stockh) 146 1989 104 106
36. H.E. Murray, A.W. Anhalt, R. Lessard, R.K. Schacter, J.B. Ross, and W.D. Stewart A 12-month treatment of severe psoriasis with acitretin: Results of a Canadian open multicentre trial J Am Acad Dermatol 24 1991 598 602
37. H.S. Young, A.M. Summers, I.R. Read, D.A. Fairhurst, D.J. Plat, and E. Camapalani Interaction between genetic control of vascular endothelial growth factor production and retinoid responsiveness in psoriasis J Invest Dermatol 126 2006 453 459
38. T. Pilkigton, and R.N. Brogden Acitretin: A review of its pharmacology and therapeutic use Drugs 43 1992 597 627
39. P.J. McNamara, R.C. Jewell, B.K. Jensen, and C.J. Brindley Food increases the bioavailability of acitretin J Clin Pharmacol 28 1988 1051 1055
40. S. Urien, P. Claudepierre, J. Meyer, R. Brandt, and J.P. Tillement Comparative binding of etretinate and acitretin to plasma proteins and erythrocytes Biochem Pharmacol 44 1992 1891 1893
41. J.H. Saurat Systemic retinoids: What's new Dermatol Clin 16 1998 331 340
42. R.C. Chou, R. Wyss, C.A. Huselton, and U.W. Wiegand A newly discovered xenobiotic metabolic pathway: Ethyl ester formation Life Sci 49 1991 PL 169 PL172
43. K.M. Knights, R. Gasser, and W. Klemisch In vitro metabolism of acitretin by human liver microsomes: evidence of an acitretinoyl-coenzyme A thioester conjugate in the transesterification to etretinate Biochem Pharmacol 60 2000 507 516
44. I.R. Webber, and D.J. Back Effect of etretinete on cyclosporin metabolism in vitro Br J Dermatol 128 1993 42 44
45. H. Gollnick, R. Bauer, C. Brindley, C.E. Orfanos, G. Plewit, and H. Wokalek Acitretin versus etretinate in psoriasis. Clinical and pharmacokinetic results of a German multicenter study J Am Acad Dermatol 19 1988 458 469
46. F.G. Larsen, P. Jakobsen, H. Eriksen, J. Grønhøj, K. Kragballe, and F. Nielsen-Kudsk The pharmacokinetics of acitretin and its 13-cis-metabolite in psoriatic patients Clin Pharmacol 31 1991 477 483
47. U.W. Wiegand, and R.C. Chou Pharmacokinetics of acitren and etretinate J Am Acad Dermatol 39 1998 S25 S33
48. O. Rollman, and I. Pihl-Lundin Acitretin excretion into human breast milk Acta Derm Venereol 70 1990 487 490
49. C. Goumy, L. Gouas, G. Marceau, K. Coste, L. Veronese, and D. Gallot Retinod Pathway and congenital diaphragmatic hernia: Hypothesis from the analysis of chromosomal abnormalities Fetal Diagn Ther 28 2010 129 139
50. A. Ozawa, M. Ohkido, Y. Haruki, H. Kobayashi, A. Ohkawara, and Y. Ohno Treatments of generalized pustular psoriasis: A multicenter study in Japan J Dermatol 26 1999 141 149
51. C.S. Lee, and K. Li A review of acitretin for the treatment of psoriasis Expert Opin Drug Saf 8 2009 769 779
52. E. Sbidian, A. Maza, H. Montaudié, A. Gallini, S. Aractingi, and F. Aubin Efficacy and safety of oral retinoids in different psoriasis subtypes: A systematic literature review J Eur Acad Dermatol Venereol 25 Suppl 2 2011 28 33
53. C. Paul, A. Gallini, A. Maza, H. Montaudié, E. Sbidian, and S. Aractingi Evidence-based recommendations on conventional systemic treatments in psoriasis: systematic review and expert opinion of a panel of dermatologists J Eur Acad Dermatol Venereol 25 Suppl 2 2011 2 11
54. A. Lassus, J.M. Geiger, M. Nyblom, T. Virrankoski, M. Kaartamaa, and L. Ingervo Treatment of severe psoriasis with etretin (RO 10-1670) Br J Dermatol 117 1987 333 341
55. H. Wolska, S. Jablonska, and Y. Bounameaux Etretinate in severe psoriasis: results of double-blind study and maintenance therapy in pustular psoriasis J Am Acad Dermatol 9 1983 883 889
56. J.M. Geiger, and B.M. Czarnetzld Acitretin (Ro 10-1670, etretin): overall evaluation of clinical studies Dermatologica 176 1988 182 190
57. L. Buccheri, B.R. Katchen, A.J. Karter, and S.R. Cohen Acitretin therapy is effective for psoriasis associated with human immunodeficiency virus infection Arch Dermatol 133 1997 711 715
58. B. Strober, E. Berger, J. Cather, D. Cohen, J.J. Crowley, and K.B. Gordon A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach J Am Acad Dermatol 61 1 Suppl 1 2009 S1 S46
59. D. Pathirana, A.D. Ormerod, P. Saiag, C. Smith, P.I. Spuls, and A. Nast European S3-Guidelines on the systemic treatment of psoriasis vulgaris J Eur Acad Dermatol Venereol 23 Suppl 2 2009 5 70
60. H.P. Gollnick Oral retinoids - efficacy and toxicity in psoriasis Br J Dermatol 135 Suppl 49 1996 6 17
61. M.R. Ling Acitretin: Optimal dosing strategies J Am Acad Dermatol 41 1999 S13 S17
62. M.T. Goldfarb, C.N. Ellis, A.K. Gupta, T. Tincoff, T.A. Hamilton, and J.J. Voorhees Acitretin improves psoriasis in a dose-dependent fashion J Am Acad Dermatol 18 1988 655 662
63. S. Dogra, A. Jain, and A.J. Kanwar Efficacy and safety of acitretin in three fixed mg in adult patients with severe plaque type psoriasis: A doses of 25, 35 and 50 randomized, double blind, parallel group, dose ranging study J Eur Acad Dermatol Venereol En prensa. 2012 10.1111/j.1468-3083.2012.04644.x
64. K. Haushalter, E.J. Murad, T.S. Dabade, R. Rowell, D.J. Pearce, and S.R. Feldman Efficacy of low-dose acitretin in the treatment of psoriasis J Dermatolog Treat 2 2011 86 89
65. D.J. Pearce, S. Klinger, K.K. Ziel, E.J. Murad, R. Rowell, and S.R. Feldman Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis Arch Dermatol 142 2006 1000 1004
66. L. Naldi, and C.E.M. Griffiths Traditional therapies in the management of moderate to severe chronic plaque psoriasis: an assessment of the benefits and risks Br J Dermatol 152 2005 597 615
67. K. Kragballe, C.T. Jansen, J.M. Geiger, J.R. Bjerke, E.S. Falk, and L. Gip A double-blind comparison of acitretin and etretinate in the treatment of severe psoriasis: Results of a Nordic multicentre study Acta Dermatol Venereol 69 1989 35 40
68. P. Berbis, J.M. Geiger, C. Vaisse, C. Rognin, and Y. Privat Benefit of progressively increasing doses during the initial treatment with acitretin in psoriasis Dermatologica 178 1989 88 92
69. A. Menter, N.J. Korman, C.A. Elmets, S.R. Feldman, J.M. Gelfand, and K.B. Gordon Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents J Am Acad Dermatol 61 2009 451 485
70. P.C. Van de Kerkhof, F. Cambazard, P.E. Hutchinson, E. Haneke, E. Wong, and P. Souteyrand The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis Br J Dermatol 138 1998 84 89
71. A. Robinson, A.S. van Voorhees, S. Hsu, N.J. Korman, M.G. Lebwohl, and B.F Bebo Jr. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation J Am Acad Dermatol 67 2012 279 288
72. A. Lassus, and J.M. Geiger Acitretin and etretinate in the treatment of palmoplantar pustulosis. A double-blind comparative trial Br J Dermatol 119 1988 755 759
73. A. Tosti, C. Ricotti, P. Romanelli, N. Cameli, and B.M. Piraccini Evaluation of the efficacy of acitretin therapy for nail psoriasis Arch Dermatol 145 2009 269 271
74. M.M. Mukai, I.F. Poffo, B. Werner, F.M. Brenner, and J.H. Lima Filho NAPSI utilization as an evaluation method of nail psoriasis in patients using acitretin An Bras Dermatol 87 2012 256 262
75. R.P. Katugampola, and A.Y. Finlay Oral retinoids therapy for disorders of keratinization: A single-centre retrospective 25 years' experience on 23 patients Br J Dermatol 154 2006 267 276
76. H.I. Katz, J. Waalen, and E.E. Leach Acitretin in psoriasis: An overview of adverse effects J Am Acad Dermatol 41 1999 S7 S12
77. O. Rüst, and T. Tufli Side effects of oral retinoid Ro 10-9359 on the unaffected skin of psoriatic patients: Retinoid dermatitis Schweiz Med Wochenschr 109 1979 1921 1925
78. D. Seckin, and A. Yildiz Repigmentation and curling of hair after acitretin therapy Australas J Dermatol 50 2009 214 216
79. T.J. Van Dizhuijsen, U.J. van Haelst, R.J. van Dooren-Greebe, P.C. van de kerkhof, and S.H. Yap Severe hepatotoxic reaction with progression to cirrhosis after use o a novel retinoid (acitretin) J Hepatol 11 1990 185 188
80. Y. Shirakami, S-A. Lee, R.D. Clugston, and W.S. Blaner Hepatic metabolism of retinoids and disease associations Biochim Biophys Acta 1821 2012 124 136
81. H.I. Ratz, J. Waalen, and E.E. Leach Acitretin in psoriasis: An overview of adverse effects J Am Acad Dermatol 41 1999 S7 S12
82. A.K. Gupta, M.T. Goldfarb, C.N. Ellis, and J.J. Voorhees Side-effect profile of acitretin therapy in psoriasis J Am Acad Dermatol 20 1989 1088 1093
83. J. Starling, and J. Koo Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effects J Drugs Dermatol 4 2005 690 696
84. Y. Moskowitz, E. Leibowitz, M. Ronen, and E. Aiel Pseudotumor cerebro induced by vitamin A combined with minocycline Ann Ophthalmol 25 1993 306 308
85. J. McGuire, and J.P. Lawson Skeletal changes associated with chronic Isotretinoin and etretinate administration Dermatologica 175 1987 S169 S181
86. R.J. van Dooren-Greebe, J.A. Lemmens, T. de Boo, N.M. Hangx, A.L. Kuijpers, and P.C. van de Kerkhof Prolonged treatment with oral retinoids in adults: No influence on the frequency and severity of spinal abnormalities Br J Dermatol 134 1996 71 76
87. P. Vestergaard, L. Rejnmark, and L. Mosekilde High-dose treatment with vitamin a analogues and risk of fractures Arch Dermatol 146 2010 478 482
88. E.A. McMullen, P. McCarron, A.D. Irvine, O.M. Dolan, and G.E. Allen Association between long-term acitretin therapy and osteoporosis: No evidence of increased risk Clin Exp Dermatol 28 2003 307 309
89. R.S. Larson, and M.S. Tallman Retinoica cid syndrome: manifestations, pathogenesis, and treatment Best Pract Res Clin Haematol 16 2003 453 461
90. S.R. Frankel, A. Eardley, G. Lauwers, M. Weiss, and R.P Warrell Jr. The «retinoica cid syndrome» in acute promyelocytic leukemia Ann Intern Med 117 1992 292 296
91. C. Cuhadaroglu, D. Korular, M. Erelel, E. Kiyan, and Z. Kilicaslan Respiratory disress with acitretin, reversal by corticosteroid Dermatol Online J 7 2001 5
92. W. Gu, G. Zhao, and F. Shi Acitretin-induced retinoic acid syndrome J Am Acad Dermatol 65 2011 e148 e149
93. D. Liu, F. Cao, X. Yan, X. Chen, Y. Chen, and Y. Tu Retinoic acid syndrome in a patient with psoriasis Eur J Dermatol 19 2009 632 634
94. E.J. Lammer, D.T. Chen, R.M. Hoar, N.D. Agnish, P.J. Benke, and C.J. Curry Retinoic acid embryopathy N Engl J Med 313 1985 837 841
95. M. David, E. Hodak, and N.J. Lowe Adverse effects of retinoids Med Toxicol Adverse Drug Exp 3 1988 273 288
96. T.O. Bleiker, J.F. Bourke, R.A. Gram-Brown, and P.E. Hutchison Etretinate may work where acitretin fails Br J Dermatol 136 1997 368 370
97. J. Hayes, and J. Koo Depression and acitretin: a true association or a class labeling J Drugs Dermatol 10 2011 409 412
98. A. Vahlquist Long-term safety of retinoid therapy J Am Acad Dermatol 27 Suppl 1992 S29 S33
99. R. Mittal, S. Malhotra, P. Pandhi, I. Kaur, and S. Dogra Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: A randomized, double-blind, placebo-controlled clinical trial Arch Dermatol 145 2009 387 393
100. H. Robertshaw, and P.S. Friedmann Pioglitazone: A promising therapy for psoriasis Br J Dermatol 152 2005 189 191
101. H.H. Roenigk Jr., J.P. Callen, C.A. Guzzo, H.I. Katz, and N. Lowe Effects of acitretin on the liver J Am Acad Dermatol 41 1999 584 588
102. P. Berbis, H. Bun, J.M. Geiger, C. Rognin, A. Durand, and A. Serradimigni Acitretin (RO 10-1670) and oral contraceptives: interaction study Arch Dermatol Res 280 1988 388 389
103. R.P. Warrell Jr., S.R. Frankel, W.H. Miller Jr., D.A. Scheinberg, L.M. Itri, and W.N. Hittelman Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid) N Engl J Med 324 1991 1385 1393
104. F.L. Meyskens Jr., and A. Manetta Prevention of cervical intraepithelial neoplasia and cervical cancer Am J Clin Nutr 62 1995 1417S 1419S
105. J.J. DiGiovanna Retinoid chemoprevention in the high-risk patient J Am Acad Dermatol 39 1998 S82 S85
106. R.M. Niles Signaling pathways in retinoid chemoprevention and treatment of cancer Mutat Res 555 2004 81 96
107. K. Takai, M. Okuno, I. Yasuda, R. Matsushima-Nishiwaki, T. Uematsu, and H. Tsurumi Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data Intervirology 48 2005 39 45
108. J.Y. Han, J.S. Choi, J.M. Chun, H.D. Park, S.Y. Lee, and C.H. Kim Pregnancy outcome of women transfused during pregnancy with blood products inadvertently obtained from donors treated with acitretin J Obstet Gynaecol 29 2009 694 697
109. B. Sengor, D. Bayramgurler, B. Muezzinoglu, L. Altintas, N. Bilen, and R. Apaydin Effects of acitretin on spermatogenesis of rats J Eur Acad Dermatol Venereol 20 2006 689 692
110. J.M. Geiger, and M. Walker Is there a reproductive safety risk in male patients treated with acitretin (neotigason/soriatane?) Dermatology 205 2002 105 107
111. Y.S. Bae, A.S. van Voorhees, S. Hsu, N.J. Korman, M.G. Lebwohl, and M. Young Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation J Am Acad Dermatol 67 2012 459 477
112. M. Lebwohl, A. Menter, J. Koo, and S.R. Feldman Combination therapy to treat moderate to severe psoriasis J Am Acad Dermatol 50 2004 416 430
113. S. Domm, and U. Mrowietz Combination therapy in the treatment of psoriasis J Dtsch Dermatol Ges 9 2011 94 98
114. P. Ghasri, B.A. Yentzer, T.S. Dabade, and S.R. Feldman Acitretin for the treatment of psoriasis: an assessment of national trends J Drugs Dermatol 10 2011 873 877
115. H.I. Katz Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: Review of the literature and results of a survey sent to 100 dermatologists J Am Acad Dermatol 37 1997 S62 S68
116. J.H. Rim, J.Y. Park, Y.B. Choe, and J.I. Youn The efficacy of calcipotriol + acitretin combination therapy for psoriasis: Comparison with acitretin monotherapy Am J Clin Dermatol 4 2003 507 510
117. J. Hu, R. Balkrishnan, F. Camacho, W. Lang, D.J. Pearce, and A.B. Fleischer Jr. The frequent use of oral retinoids in combination with other treatments for psoriasis: A retrospective analysis J Cutan Med Surg 8 2004 411 414
118. L. Winterfield, J. Cather, J. Cather, and A. Menter Changing paradigms in dermatology: Nuclear hormone receptors Clin Dermatol 21 2003 447 454
119. C. Carlberg, and J.H. Saurat Vitamin D-retinoid association: Molecular basis and clinical applications J Invest Dermatol Symp Proc 1 1996 82 86
120. C.E. Orfanos, G.K. Steigleder, H. Pullmann, C.E. Orfanos, G.K. Steigleder, H. Pullmann, and P.H. Bloch Oral retinoid and UVB radiation: A new, alternative treatment for psoriasis on an out-patient basis Acta Derm Venereol 59 1979 241 244
121. S. Parker, P. Coburn, C. Lawrence, J. Marks, and S. Shuster A randomized double-blind comparison of PUVA-etretinate and PUVA-placebo in the treatment of chronic plaque psoriasis Br J Dermatol 110 1984 215 220
122. C.E.M. Griffiths, C.M. Clark, R.J.G. Chalmers, A. Li Wan Po, and H.C. Williams A systematic review of treatments for severe psoriasis Health Technol Assess 4 2000 1 125
123. M. Lebwohl, L. Drake, A. Menter, J. Koo, A.B. Gottlieb, and M. Zanolli Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis J Am Acad Dermatol 45 2001 544 553
124. P.I. Spuls, M. Rozenblit, and M. Lebwohl Retrospective study of the efficacy of narrowband UVB and acitretin J Dermatol Treat 14 Suppl 2 2003 17 20
125. N.J. Lowe, J.H. Prystowsky, T. Bourget, J. Edelstein, S. Nychay, and R. Armstrong Acitretin plus UVB therapy for psoriasis: comparisons with placebo plus UVB and acitretin alone J Am Acad Dermatol 24 1991 591 594
126. T. Ruzicka, C. Sommerburg, O. Braun-Falco, W. Koster, W. Lengen, and W. Lensing Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis Arch Dermatol 126 1990 482 486
127. A. Tanew, A. Guggenbichler, H. Honigsmann, J.M. Geiger, and P. Fritsch Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study J Am Acad Dermatol 25 1991 682 684
128. M. Ozdemir, B. Engin, I. Baysal, and I. Mevlitoglu A randomized comparison of acitretin-narrow-band TL-01 phototherapy and acitretin-psoralen plus ultraviolet A for psoriasis Acta Derm Venereol 88 2008 589 593
129. W. Lapolla, B.A. Yentzer, J. Bagel, C.R. Halvorson, and S.R. Feldman A review of phototherapy protocols for psoriasis treatment J Am Acad Dermatol 64 2011 936 949
130. H.H. Roenigk Jr. Acitretin combination therapy J Am Acad Dermatol 41 1999 S18 S21
131. M.M. Rosenbaum, and H.H. Roenigk Treatment of generalized pustular psoriasis with etretinate (Ro-10-0359) and methotrexate J Am Acad Dermatol 10 1984 357 361
132. K.E. Lowenthal, P.J. Horn, and R.E. Kalb Concurrent use of methotrexate and acitretin revisited J Dermatol Treat 19 2008 22 26
133. B. Brechtel, U. Wellenreuther, E. Toppe, and B.M. Czarnetzki Combination of etretinate with cyclosporine in the treatment of sever recalcitrant psoriasis J Am Acad Dermatol 30 1994 1023 1024
134. A.L.A. Kuijpers, R.J. van Dooren-Greebe de, and P.C.M. van der kerkhof Failure of combination therapy with acitretin and cyclosporin A in 3 patients with erythrodermic psoriasis Dermatology 194 1997 88 90
135. F. Kokelj, C. Plozzer, P. Torsello, and G. Trevisan Efficacy of cyclosporine plus etretinate in the treatment of erythrodermic psoriasis (three case reports) J Eur Acad Dermatol Venereol 11 1998 177 179
136. M. Rosenbach, S. Hsu, N.J. Korman, M.G. Lebwohl, M. Young, and B. Bebo Treatment of erythrodermic psoriasis: From the medical board of the National Psoriasis Foundation J Am Acad Dermatol 62 2010 655 662
137. J. Conley, J. Nanton, S. Dhawan, D.J. Pearce, and S.R. Feldman Novel combination regimens: biologics and acitretin for the treatment of psoriasis-a case series J Dermatolog Treat 17 2006 86 89
138. E.C.A. Smith, C.H. Riddle, A. Menter, and M. Lebwohl Combining systemic retinoids with biologic agents for moderate to severe psoriasis Int J Dermatol 47 2008 514 518
139. S. Phillipp, D. Willsmann-Theis, A. Weyergraf, S. Rotterdam, Y. Frambach, S. Gerdes, and R. Mössner Combination of adalimumab with traditional systemic antipsoriatic drugs-a report of 39 cases J Dtsch Dermatol Ges 10 2012 821 837
140. P.A. Foley, C. Quirk, J.R. Sullivan, C. Dolianitis, S.P. Hack, and K. Thirunavukkarasu Combining etanercept with traditional agents in the treatment of psoriasis: A review of the clinical evidence J Eur Acad Dermatol Venereol 24 2010 1135 1143
141. E. Gallo, M. Llamas-Velasco, E. Daudén, and A. García-Diez Refractory generalized pustular psoriasis responsive to a combination of adalimumab and acitretin Int J Dermatol En prensa 2012 10.1111/j. 1365-4632.2012.05472.x Epub aheadof print
142. J. Koo Systemic sequential therapy of psoriasis: A new paradigm for improved therapeutic results J Am Acad Dermatol 41 1999 S25 S28
143. D.J. Gawkrodger on behalf of the Therapy Guidelines and Audit Subcommittee of the British Association of Dermatologists Current management of psoriasis J Dermatol Treat 8 1997 27 55
144. M.A. Menter, J.A. See, W.J.C. Amend, C.N. Ellis, G.G. Krueger, and M. Lebwohl Prooceedings of the Psoriasis Combination and Rotation Therapy Conference J Am Acad Dermatol 34 1996 315 321
145. G. Siegenthaler, D. Gumowski-Sunck, and J.H. Saurat Metabolism of natural retinoids in psoriasis J Invest Dermatol 95 1990 47S 48S
146. J.L. Napoli Retinoic acid biosynthesis and metabolism FASEB J 10 1996 993 1001